These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20949245)

  • 1. [The HPA axis in the pathogenesis of chronic fatigue syndrome].
    Ursini F; Succurro E; Grembiale A; Gagliardi DA; Arturi F
    Clin Ter; 2010; 161(5):461-4. PubMed ID: 20949245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HPA axis and the genesis of chronic fatigue syndrome.
    Cleare AJ
    Trends Endocrinol Metab; 2004 Mar; 15(2):55-9. PubMed ID: 15036250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F; Karaca Z; Unluhizarci K; Kelestimur F
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Van Houdenhove B; Cosyns P; Claes SJ
    Neuropsychobiology; 2007; 55(2):112-20. PubMed ID: 17596739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH; Sharpe M; Clements A; Dowling B; Hawton KE; Cowen PJ
    Biol Psychiatry; 1998 Feb; 43(3):236-7. PubMed ID: 9494707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U
    J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.
    Surapaneni DK; Adapa SR; Preeti K; Teja GR; Veeraragavan M; Krishnamurthy S
    J Ethnopharmacol; 2012 Aug; 143(1):91-9. PubMed ID: 22771318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroaetiology of chronic fatigue syndrome: an overview.
    Sanders P; Korf J
    World J Biol Psychiatry; 2008; 9(3):165-71. PubMed ID: 17853290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ; Prickett TC; Mulder RT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic fatigue syndrome in school children].
    Kawa K
    Nihon Rinsho; 1992 Nov; 50(11):2606-11. PubMed ID: 1287237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?
    Van Houdenhove B; Van Den Eede F; Luyten P
    Med Hypotheses; 2009 Jun; 72(6):701-5. PubMed ID: 19237251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
    Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPA-axis dysfunction in chronic fatigue syndrome: clinical implications.
    Van Den Eede F; Moorkens G
    Psychosomatics; 2008; 49(5):450. PubMed ID: 18794517
    [No Abstract]   [Full Text] [Related]  

  • 15. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome.
    Demitrack MA; Crofford LJ
    Ann N Y Acad Sci; 1998 May; 840():684-97. PubMed ID: 9629295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroendocrinology of chronic fatigue syndrome.
    Cleare AJ
    Endocr Rev; 2003 Apr; 24(2):236-52. PubMed ID: 12700181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.
    Jerjes WK; Peters TJ; Taylor NF; Wood PJ; Wessely S; Cleare AJ
    J Psychosom Res; 2006 Feb; 60(2):145-53. PubMed ID: 16439267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome.
    Jerjes WK; Cleare AJ; Wessely S; Wood PJ; Taylor NF
    J Affect Disord; 2005 Aug; 87(2-3):299-304. PubMed ID: 15922454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.